Pfizer and Takeda, which previously backed a $15m series A, have returned to back a $76m series B round for Cortexyme.

Cytrellis has raised $28.5m from investors including pharmaceutical developer Merz as it continues clinical trials on its handheld dermatological device for aging skin.

GV is reportedly leading a funding round for Lime, a bike-sharing platform also backed by NGP Capital and the Stanford-StartX fund.

Trust Ventures has secured $35m for its inaugural fund from investors including Koch Disruptive Technologies to invest in sectors where public policy is proving a hurdle to startups.

Visa, CreditEase and Commerzbank-backed Marqeta has added $45m to its coffers, securing funding from investors including Goldman Sachs.

BlueVine, backed by Rakuten and Citi, will use the money to expand its product offering and accelerate recruitment of its research and development team.

The Sinar Mas-backed company has nearly doubled the size of its series C round to almost $112m after securing $60m from CLSA and Kamet Capital Partners.

Bertelsmann Asia Investments was among the returning investors in a $70m series B+ round, which followed an initial $100m series B in February this year.